Outcomes and Treatment Patterns of Adding a Third Agent to 2 OADs in Patients With Type 2 Diabetes

Journal of Managed Care Pharmacy
doi 10.18553/jmcp.2014.20.5.501
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Academy of Managed Care Pharmacy

Related search

Different Glycaemic Patterns in Patients With Steroid Diabetes and Type 2 Diabetes

Endocrine Abstracts
2015English

Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes

Clinical Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Clinical Potential of Treatment With Semaglutide in Type 2 Diabetes Patients

Drugs in Context
Molecular MedicinePharmacology
2019English

Improvement in Neuropathy Outcomes With Normalizing HbA1c in Patients With Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2018English

Microvascular Outcomes in Type 2 Diabetes

The Lancet Diabetes and Endocrinology
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Pharmaceutical Consultation as a Tool to Improve Health Outcomes for Patients With Type 2 Diabetes

Brazilian Journal of Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2013English

An Assessment of Attitudes, Behaviors, and Outcomes of Patients With Type 2 Diabetes

Journal of the American Board of Family Medicine
EnvironmentalPublic HealthFamily PracticeOccupational Health
2009English

Approaches to Treatment of Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2008English

Potential of Liraglutide in the Treatment of Patients With Type 2 Diabetes

Vascular Health and Risk Management
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy